HomeStock ScreenerTijaria PolypipesIntrinsic Value

Tijaria Polypipes Intrinsic Value

Tijaria Polypipes (TIJARIA) median intrinsic value is ₹18.95 from 1 valuation models (range ₹19–₹19), vs current price ₹7.58 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Check Tijaria Polypipes marketcap in USD to track the company's total market size over time.

Market Price (CMP)
₹7.58
Primary Intrinsic Value
₹18.95
Market Cap
₹22.0 Cr
+150.0% Upside
Median Value
₹18.95
Value Range
₹19 - ₹19
Assessment
Trading Below Calculated Value
Safety Margin
60.0%

TIJARIA Valuation Methods Summary — DCF, Graham Number & P/E

Tijaria Polypipes intrinsic value across 1 models vs current price ₹7.58 — upside/downside and value range per method. See TIJARIA book value to compare market price against book value per share.

Method Type Intrinsic Value Range Upside/Downside Details
Simple DCF (5Y) dcf ₹18.95 ₹15.16 - ₹22.74 +150.0% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

TIJARIA Intrinsic Value vs Market Price — All Valuation Models

Tijaria Polypipes fair value range ₹19–₹19 vs current market price ₹7.58 across 1 valuation models. For current market price and key ratios, visit Tijaria Polypipes stock price NSE.

TIJARIA Intrinsic Value Analysis — Undervalued or Overvalued?

Tijaria Polypipes median intrinsic value ₹18.95, current price ₹7.58 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.

What is the intrinsic value of TIJARIA?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Tijaria Polypipes (TIJARIA) is ₹18.95 (median value). With the current market price of ₹7.58, this represents a +150.0% variance from our estimated fair value.

The valuation range spans from ₹18.95 to ₹18.95, indicating ₹18.95 - ₹18.95.

Is TIJARIA undervalued or overvalued?

Based on our multi-method analysis, Tijaria Polypipes (TIJARIA) appears to be trading below calculated value by approximately 150.0%.

TIJARIA Financial Health — Key Ratios vs Industry Benchmarks

Tijaria Polypipes financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 0.57 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Return on Equity 2.9% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency

TIJARIA Cash Flow Quality — Operating & Free Cash Flow

Tijaria Polypipes operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹5 Cr ₹5 Cr Positive Free Cash Flow 8/10
March 2025 ₹-5 Cr ₹-5 Cr Negative Cash Flow 3/10
March 2024 ₹4 Cr ₹4 Cr Positive Free Cash Flow 8/10
March 2023 ₹-5 Cr ₹-5 Cr Negative Cash Flow 3/10
March 2022 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10